Viewing Study NCT06622603


Ignite Creation Date: 2025-12-24 @ 7:39 PM
Ignite Modification Date: 2026-01-22 @ 4:24 PM
Study NCT ID: NCT06622603
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-10-02
First Post: 2024-09-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More
Sponsor: Seoul National University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gout View
None Uric Acid View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Febuxostat View
None Allopurinol View